Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
(RTTNews) - Cassava Sciences, Inc. (SAVA), a drug maker focused on Alzheimer's disease, announced on Monday that it has appointed Richard Barry as Chief Executive Officer. On July 17, the Board ...
WASHINGTON, Sept 26 (Reuters) - Shares of Cassava Sciences (SAVA.O), opens new tab fell 10% in post-market trading on Thursday after the U.S. Securities and Exchange Commission charged the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results